Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Lantheus Holdings, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $390.14M came in.
  • Fiscal year ended 2025-12-31: from investing, $627.17M went out.
  • Fiscal year ended 2025-12-31: from financing, $316.58M went out.
  • Fiscal year ended 2025-12-31: change in cash, $553.66M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31$390.14M-$627.17M-$300.02M-$1.11M-$26.34M$7.15M$3.73M*-$553.66M
2024-12-31$544.75M-$226.01M-$100.00M-$318.00K$0.00-$22.61M$3.45M$947.00K*$199.20M
2023-12-31$305.26M$5.94M$0.00-$717.00K$0.00-$14.39M$1.93M$298.04M
2022-12-31$281.78M-$276.55M-$75.00M-$175.38M$557.75M-$7.76M$1.38M$10.71M*$316.59M
2021-12-31$53.92M$3.68M$0.00-$43.35M$0.00-$2.05M$767.00K$5.29M*$17.96M
2020-12-31$16.40M-$4.91M$0.00-$15.49M$0.00-$2.13M$683.00K-$4.92M*-$10.22M
2019-12-31$80.38M-$22.06M-$275.38M$199.46M-$2.45M$573.00K-$1.08M*-$20.48M
2018-12-31$61.19M-$19.13M-$2.86M$0.00-$3.39M$428.00K$1.15M*$37.11M
2017-12-31$54.78M-$16.31M-$286.69M$274.31M-$2.85M$187.00K$1.60M*$25.11M
2016-12-31$49.64M$3.28M-$78.73M$0.00-$602.00K$50.90M-$1.79M*$22.58M
2015-12-31$21.76M-$13.15M-$1.90M$360.44M-$8.00M-$97.00K$73.54M-$422.98M*$8.86M
2014-12-31$11.59M-$7.68M-$71.00K$0.00$0.00*$0.00$0.00-$2.23M*$1.16M
2013-12-31-$15.57M-$3.48M-$106.00K-$123.00K-$1.31M$8.00M$400.00K-$1.25M*-$14.74M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$92.20M*-$2.02M*-$248.00K*-$2.10M*$6.86M*
2026-03-31$125.13M$25.99M-$216.00K-$15.70M$0.00$4.29M*$139.47M
2025-12-31$90.18M*-$11.51M*-$100.02M*-$353.00K*-$1.10M*$681.00K*
2025-09-30$105.29M*-$319.47M*-$100.00M*-$292.00K*-$759.00K*$142.00K*$1.74M*
2025-06-30$87.11M*-$232.47M*-$63.00K*-$795.00K*$2.44M*-$100.00M*
2025-03-31$107.56M-$63.72M-$402.00K-$23.69M$1.98M$3.89M*$25.73M
2024-12-31$157.73M*-$6.60M*-$100.00M*$58.00K*-$892.00K*-$494.00K*-$2.33M*
2024-09-30$175.06M*-$67.80M*$0.00*$252.00K*-$1.30M*$1.63M*
2024-06-30$84.72M*-$45.09M*-$444.00K*-$1.01M*$1.55M*
2024-03-31$127.24M-$106.53M-$184.00K-$19.42M$1.82M$934.00K*$4.63M
2023-12-31$112.29M*-$12.07M*-$32.00K*-$773.00K*$354.00K*
2023-09-30$116.74M*$83.22M*-$157.00K*-$1.00M*$993.00K*
2023-06-30-$32.27M*-$20.70M*-$231.00K*-$1.47M*$0.00*-$2.35M*
2023-03-31$108.50M-$44.51M-$297.00K-$11.15M$940.00K$1.84M*$55.22M
2022-12-31$105.35M*-$264.72M*-$167.49M*-$588.00K*$0.00*$485.92M*
2022-09-30$93.57M*-$6.09M*-$2.67M*-$843.00K*$798.00K*
2022-06-30$72.60M*-$4.34M*-$2.61M*-$824.00K*$0.00*$1.42M*
2022-03-31$10.26M-$1.39M-$2.61M-$5.50M*$577.00K$6.85M
2021-12-31$13.89M*-$4.54M*-$2.59M*-$187.00K*-$1.00K*
2021-09-30$4.34M*-$2.42M*-$2.62M*-$67.00K*$431.00K*
2021-06-30$25.87M*-$2.66M*-$2.56M*-$193.00K*$0.00*$2.04M*
2021-03-31$9.82M$13.30M-$35.57M-$1.60M*$337.00K-$11.69M
2020-12-31$569.00K*-$3.79M*-$4.33M*$0.00*-$47.00K*$0.00*
2020-09-30$8.57M*-$3.74M*-$4.13M*$0.00*-$50.00K*$317.00K*-$3.40M*
2020-06-30-$2.16M*$5.31M*-$4.48M*-$485.00K*$0.00*-$1.52M*
2020-03-31$9.41M-$2.70M-$2.55M-$1.55M$366.00K$2.79M
2019-12-31$22.42M*-$4.74M*-$2.56M*$0.00*-$44.00K*$0.00*
2019-09-30$26.44M*-$3.34M*-$2.57M*$0.00*-$346.00K*$291.00K*
2019-06-30$21.05M*-$3.43M*-$269.53M*-$944.00K*$0.00*$197.55M*
2019-03-31$10.47M-$10.55M-$717.00K-$1.12M$282.00K-$1.34M
2018-12-31$17.31M*-$7.37M*-$716.00K*$0.00*-$218.00K*$0.00*$8.82M*
2018-09-30$24.28M*-$5.00M*-$715.00K*$0.00*-$736.00K*$222.00K*$18.12M*
2018-06-30$20.28M*-$5.63M*-$716.00K*$0.00*-$1.72M*$0.00*$12.72M*
2018-03-31-$666.00K-$1.14M-$715.00K*$0.00-$709.00K$206.00K-$2.55M
2017-12-31$13.09M*-$5.95M*-$715.00K*$0.00*-$172.00K*$0.00*$2.04M*$8.21M*
2017-09-30$15.60M*-$3.29M*-$714.00K*$0.00*-$1.12M*$187.00K*$0.00*$10.92M*
2017-06-30$20.57M*-$2.50M*-$714.00K*$0.00*-$1.20M*$0.00*$0.00*$16.27M*
2017-03-31$5.52M-$4.56M-$284.55M$274.31M-$355.00K$0.00-$74.00K-$587.00K*-$10.30M
2016-12-31$12.78M*-$2.36M*-$20.94M*$0.00*-$50.00K*$9.30M*-$570.00K*-$2.02M*
2016-09-30$15.45M*-$1.05M*-$55.93M*$11.00K*$39.83M*-$1.66M*
2016-06-30$17.64M*-$736.00K*-$928.00K*$0.00*$15.97M*
2016-03-31$3.78M$7.42M-$933.00K$0.00$0.00$0.00-$11.00K$10.28M
2015-12-31$12.63M*-$4.73M*-$931.00K*$0.00*$0.00*$0.00*$0.00*$6.67M*
2015-09-30$5.42M*-$2.31M*$0.00*$0.00*$0.00*-$3.01M*-$278.00K*
2015-06-30-$11.44M*-$2.61M*$5.51M*-$8.54M*
2015-03-31$15.16M-$3.50M-$18.00K$11.00M
2014-12-31-$3.88M*-$2.83M*-$19.00K*$0.00*-$13.00K*-$7.39M*
2014-09-30$20.51M*-$1.59M*$0.00*$0.00*-$7.33M*$11.11M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B